Elanco Animal Health (ELAN) EBIT Margin (2017 - 2026)

Elanco Animal Health has disclosed EBIT Margin across 10 years of filings, most recently posting 22.39% for Q1 2026.

• EBIT Margin for Q1 2026 came in at 22.39%, up 152.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 17.43% (up 3467.0% YoY), and the FY2025 annual result was 16.86%, up 5099.0% from the prior year.
• EBIT Margin came in at 22.39% for Q1 2026 at Elanco Animal Health, up from 13.81% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 22.39% in Q1 2026 to a low of 148.31% in Q3 2023.
• The 5-year median for EBIT Margin is 41.74% (2024), against an average of 30.39%.
• Across the five-year window, EBIT Margin plunged 9802 bps in 2023 and jumped 15482 bps in 2024, its largest moves.
• Elanco Animal Health's EBIT Margin stood at 54.52% in 2022, then declined by 14 bps to 62.13% in 2023, then climbed by 13 bps to 54.12% in 2024, then soared by 126 bps to 13.81% in 2025, then soared by 62 bps to 22.39% in 2026.
• The last three EBIT Margin figures came in at 22.39% (Q1 2026), 13.81% (Q4 2025), and 14.69% (Q3 2025), per Business Quant data.